Cargando…
Detailed Kinetics of the Direct Allo-Response in Human Liver Transplant Recipients: New Insights from an Optimized Assay
Conventional assays for quantification of allo-reactive T-cell precursor frequencies (PF) are relatively insensitive. We present a robust assay for quantification of PF of T-cells with direct donor-specificity, and establish the kinetics of circulating donor-specific T cells after liver transplantat...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3012075/ https://www.ncbi.nlm.nih.gov/pubmed/21206923 http://dx.doi.org/10.1371/journal.pone.0014452 |
_version_ | 1782195071819448320 |
---|---|
author | Tapirdamaz, Özlem Mancham, Shanta van der Laan, Luc J. W. Kazemier, Geert Thielemans, Kris Metselaar, Herold J. Kwekkeboom, Jaap |
author_facet | Tapirdamaz, Özlem Mancham, Shanta van der Laan, Luc J. W. Kazemier, Geert Thielemans, Kris Metselaar, Herold J. Kwekkeboom, Jaap |
author_sort | Tapirdamaz, Özlem |
collection | PubMed |
description | Conventional assays for quantification of allo-reactive T-cell precursor frequencies (PF) are relatively insensitive. We present a robust assay for quantification of PF of T-cells with direct donor-specificity, and establish the kinetics of circulating donor-specific T cells after liver transplantation (LTx). B cells from donor splenocytes were differentiated into professional antigen-presenting cells by CD40-engagement (CD40-B cells). CFSE-labelled PBMC from LTx-recipients obtained before and at several time points after LTx, were stimulated with donor-derived or 3(rd) party CD40-B cells. PF of donor-specific T cells were calculated from CFSE-dilution patterns, and intracellular IFN-γ was determined after re-stimulation with CD40-B cells. Compared to splenocytes, stimulations with CD40-B cells resulted in 3 to 5-fold higher responding T-cell PF. Memory and naïve T-cell subsets responded equally to allogeneic CD40-B cell stimulation. Donor-specific CD4(+) and CD8(+) T-cell PF ranged from 0.5 to 19% (median: 5.2%). One week after LTx, PF of circulating donor-specific CD4(+) and CD8(+) T cells increased significantly, while only a minor increase in numbers of T cells reacting to 3(rd) party allo-antigens was observed. One year after LTx numbers of CD4(+) and CD8(+) T cells reacting to donor antigens, as well as those reacting to 3(rd) party allo-antigens, were slightly lower compared to pre-transplant values. Moreover, CD4(+) and CD8(+) T cells responding to donor-derived, as well as those reacting to 3(rd) party CD40-B cells, produced less IFN-γ. In conclusion, our alternative approach enables detection of allo-reactive human T cells at high frequencies, and after application we conclude that donor-specific T-cell PF increase immediately after LTx. However, no evidence for a specific loss of circulating T-cells recognizing donor allo-antigens via the direct pathway up to 1 year after LTx was obtained, underscoring the relative insensitiveness of previous assays. |
format | Text |
id | pubmed-3012075 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-30120752011-01-04 Detailed Kinetics of the Direct Allo-Response in Human Liver Transplant Recipients: New Insights from an Optimized Assay Tapirdamaz, Özlem Mancham, Shanta van der Laan, Luc J. W. Kazemier, Geert Thielemans, Kris Metselaar, Herold J. Kwekkeboom, Jaap PLoS One Research Article Conventional assays for quantification of allo-reactive T-cell precursor frequencies (PF) are relatively insensitive. We present a robust assay for quantification of PF of T-cells with direct donor-specificity, and establish the kinetics of circulating donor-specific T cells after liver transplantation (LTx). B cells from donor splenocytes were differentiated into professional antigen-presenting cells by CD40-engagement (CD40-B cells). CFSE-labelled PBMC from LTx-recipients obtained before and at several time points after LTx, were stimulated with donor-derived or 3(rd) party CD40-B cells. PF of donor-specific T cells were calculated from CFSE-dilution patterns, and intracellular IFN-γ was determined after re-stimulation with CD40-B cells. Compared to splenocytes, stimulations with CD40-B cells resulted in 3 to 5-fold higher responding T-cell PF. Memory and naïve T-cell subsets responded equally to allogeneic CD40-B cell stimulation. Donor-specific CD4(+) and CD8(+) T-cell PF ranged from 0.5 to 19% (median: 5.2%). One week after LTx, PF of circulating donor-specific CD4(+) and CD8(+) T cells increased significantly, while only a minor increase in numbers of T cells reacting to 3(rd) party allo-antigens was observed. One year after LTx numbers of CD4(+) and CD8(+) T cells reacting to donor antigens, as well as those reacting to 3(rd) party allo-antigens, were slightly lower compared to pre-transplant values. Moreover, CD4(+) and CD8(+) T cells responding to donor-derived, as well as those reacting to 3(rd) party CD40-B cells, produced less IFN-γ. In conclusion, our alternative approach enables detection of allo-reactive human T cells at high frequencies, and after application we conclude that donor-specific T-cell PF increase immediately after LTx. However, no evidence for a specific loss of circulating T-cells recognizing donor allo-antigens via the direct pathway up to 1 year after LTx was obtained, underscoring the relative insensitiveness of previous assays. Public Library of Science 2010-12-29 /pmc/articles/PMC3012075/ /pubmed/21206923 http://dx.doi.org/10.1371/journal.pone.0014452 Text en Tapirdamaz et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Tapirdamaz, Özlem Mancham, Shanta van der Laan, Luc J. W. Kazemier, Geert Thielemans, Kris Metselaar, Herold J. Kwekkeboom, Jaap Detailed Kinetics of the Direct Allo-Response in Human Liver Transplant Recipients: New Insights from an Optimized Assay |
title | Detailed Kinetics of the Direct Allo-Response in Human Liver Transplant Recipients: New Insights from an Optimized Assay |
title_full | Detailed Kinetics of the Direct Allo-Response in Human Liver Transplant Recipients: New Insights from an Optimized Assay |
title_fullStr | Detailed Kinetics of the Direct Allo-Response in Human Liver Transplant Recipients: New Insights from an Optimized Assay |
title_full_unstemmed | Detailed Kinetics of the Direct Allo-Response in Human Liver Transplant Recipients: New Insights from an Optimized Assay |
title_short | Detailed Kinetics of the Direct Allo-Response in Human Liver Transplant Recipients: New Insights from an Optimized Assay |
title_sort | detailed kinetics of the direct allo-response in human liver transplant recipients: new insights from an optimized assay |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3012075/ https://www.ncbi.nlm.nih.gov/pubmed/21206923 http://dx.doi.org/10.1371/journal.pone.0014452 |
work_keys_str_mv | AT tapirdamazozlem detailedkineticsofthedirectalloresponseinhumanlivertransplantrecipientsnewinsightsfromanoptimizedassay AT manchamshanta detailedkineticsofthedirectalloresponseinhumanlivertransplantrecipientsnewinsightsfromanoptimizedassay AT vanderlaanlucjw detailedkineticsofthedirectalloresponseinhumanlivertransplantrecipientsnewinsightsfromanoptimizedassay AT kazemiergeert detailedkineticsofthedirectalloresponseinhumanlivertransplantrecipientsnewinsightsfromanoptimizedassay AT thielemanskris detailedkineticsofthedirectalloresponseinhumanlivertransplantrecipientsnewinsightsfromanoptimizedassay AT metselaarheroldj detailedkineticsofthedirectalloresponseinhumanlivertransplantrecipientsnewinsightsfromanoptimizedassay AT kwekkeboomjaap detailedkineticsofthedirectalloresponseinhumanlivertransplantrecipientsnewinsightsfromanoptimizedassay |